Clinical trials
Metabolic Diseases trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 6 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 2 |
| ModernaTX, Inc. | 2 |
| 89bio, Inc. | 1 |
| Aichi Gakuin University | 1 |
| Kyowa Kirin Co., Ltd. | 1 |
| Pfizer | 1 |
| Shire | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 16 |
| Diabetes Mellitus, Type 2 | 8 |
| Glucose Metabolism Disorders | 8 |
| Diabetes Mellitus | 7 |
| Endocrine System Diseases | 6 |
| Genetic Diseases, Inborn | 3 |
| Metabolism, Inborn Errors | 3 |
| Acid-Base Imbalance | 2 |
| Acidosis | 2 |
| Amino Acid Metabolism, Inborn Errors | 2 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.